Aphria Inc. (APHA)
Market Cap | 4.12B |
Revenue (ttm) | 393.72M |
Net Income (ttm) | -61.33M |
Shares Out | 257.91M |
EPS (ttm) | 0.30 |
PE Ratio | 43.21 |
Forward PE | 1,000.00 |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 22 |
Last Price | $12.92 |
Previous Close | $12.68 |
Change ($) | 0.24 |
Change (%) | 1.89% |
Day's Open | 12.14 |
Day's Range | 12.08 - 13.03 |
Day's Volume | 11,160,007 |
52-Week Range | 2.13 - 13.61 |
Let's look at four marijuana penny stocks that can deliver multi-fold returns once federal cannabis legalization occurs in the United States. The post 4 Marijuana Penny Stocks for a Blue-Led G...
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks over the past week, and look ahead to how the cannabis...
Investors could be in for high times.
These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for February.
Aphria shares have gained 133% since the beginning of 2020 driven by better financial performance and two sound M&A deals. The last quarter was unsurprising with stable cannabis revenue and th...
These pot growers are shattering their own revenue growth records.
Analysts say the marijuana company's solid second-quarter results bode well for investors.
But Stifel's neutral rating has not changed.
The shares of cannabis company Aphria Inc (NASDAQ:APHA) are down 5.4% at $12.31 at last check, despite a price-target hike from Stifel to $15.50 from $9.80.
While older generations give younger Americans grief, the reality is that the world has changed. And electing millennial stocks to buy could be an excellent way to forge a path to profitabilit...
Shares of Canadian cannabis company Aphria Inc. rose 4.4% in premarket trade Tuesday, after Stifel raised its stock price target to C$15.50 ($12.18) from C$9.80, and said recent results unders...
Several analysts lifted their price targets on the stock.
With the trading day about half over, the broad markets were pulling back on Friday afternoon.
Earnings, rising share prices, and a stock offering are all playing into the action.
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks over the past week, and look ahead to how the cannabis...
Cantor Fitzgerald raised its 12-month stock price target for Canadian cannabis company Aphria Inc. to C$26 from C$11.75 on Friday, to factor in its merger with Tilray Inc. even though it was u...
The marijuana company had quite a pleasant surprise on the bottom line in particular.
Aphria CEO says Democratic majority will accelerate legalization of cannabis
Aphria, a global cannabis lifestyle consumer packaged goods company, is surging today. The company reported strong Q2 earnings with a net revenue of $160.5 million, an increase of 33 percent f...
Aphria Inc. (APHA) CEO Irwin Simon on Q2 2021 Results - Earnings Call Transcript
Some good news from Aphria and HEXO has Aurora Cannabis moving in sympathy.
Aphria Inc. posted net cannabis revenue of CA$67.9 million for the second quarter of 2021 — 99% higher than in the prior-year quarter.
Aphria (APHA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Aphria Inc. (APHA) delivered earnings and revenue surprises of 100.00% and 2.12%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Cannabis stocks are active again on Thursday morning just a week before pot-friendly Democrats take power in Washington. HEXO, Aphria and a marijuana ETF are just a few of what's popping in pr...
The U.S.-listed shares of Aphria Inc. surged 3.7% in premarket trading Thursday, toward a 21-month high, after the Canada-based cannabis company reported a surprise fiscal second-quarter adjus...
SPAC Week: Whoever Wins California Wins Cannabis (Podcast Transcript)
Reports Net Revenue of $160.5 Million, an Increase of 33% from Prior Year Quarter Adjusted EBITDA of $12.6 Million Marks Seventh Consecutive Quarter of Increasing Positive Adjusted EBITDA Cash...
In the last round, 36% of recipients saved the money, If you're planning the same with the second payment, here are seven stocks to buy with your stimulus check. The post 7 Stocks to Buy With ...
Medical pot is now legal in Mexico.
Many marijuana stocks show promise in 2021, but these specific stocks have the best shot to build upon their strong performances last year. The post The Top 7 Marijuana Stocks to Buy for Janua...
These cannabis stocks currently have the most green.
A cannabis CEO makes a bullish prediction on marijuana legalization in 2021.
When is the right time to buy stock in the cannabis market? The time is now!
In the latest trading session, Aphria Inc. (APHA) closed at $8.57, marking a -0.23% move from the previous day.
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks over the past week, and look ahead to how the cannabis ...
Marijuana is now widely legal, and the industry will soon be gobbling up market share from its illicit competition.
State-level legalization and Democratic control of Congress are sending a strong 'green wave' across markets. Here are 7 marijuana stocks that are worth your investment in 2021.
Investors think the new administration in the U.S. could bring an inflection point for the industry.
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors in the cannabis sector are feeling pretty good today.
Predicting market moves proves difficult again, but cannabis investors have high hopes for the future.
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These two cannabis stocks have risk, but they also have growing sales.
Marijuana bills have come to die in the Senate, but that could change if there's a shift in power.
Legalizations passed in 2020 should become law in 2021.
Start Up Cannabis Nation (Podcast Transcript)
Earlier this month, cannabis growers Aphria (NASDAQ:APHA) and Tilray (NASDAQ:TLRY) announced a merger to create the largest enterprise in the industry by revenue.
Aphria Inc. (APHA) closed at $6.92 in the latest trading session, marking a -1.98% move from the prior day.
Cannabis growth to continue 'substantially' in 2021: Parallel Cannabis CEO
When new cannabis laws go into effect across the U.S. in 2021, the industry may see some big changes. CNBC's "Squawk on the Street" team discusses this with William Wrigley, CEO of Parallel Ca...
About APHA
Aphria cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Industry Drug Manufacturers-Specialty & Generic | |
CEO Irwin Simon | Employees 1,200 |
Stock Exchange NASDAQ | Ticker Symbol APHA |
Financial Performance
In 2020, Aphria's revenue was 543.34 million, an increase of 129.15% compared to the previous year's 237.11 million. Losses were -84.63 million, 413.0% more than in 2019.